Cargando…
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes
Ocular herpes simplex virus (HSV) infection remains a major cause of corneal blindness. Several topical and oral antiviral medications have been used to treat herpetic keratitis. Advances in topical ophthalmic antivirals have been made over the past several decades. The first antivirals that were di...
Autor principal: | Colin, Joseph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2704535/ https://www.ncbi.nlm.nih.gov/pubmed/19668521 |
Ejemplares similares
-
Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications
por: Chou, Timothy Y, et al.
Publicado: (2014) -
Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis – a multicenter, randomized, investigator-masked, parallel group study in Chinese patients
por: Lin, Tong, et al.
Publicado: (2013) -
Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study
por: Waduthantri, Samanthila, et al.
Publicado: (2018) -
Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
por: Sahin, Afsun, et al.
Publicado: (2012) -
Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023)